Drug information for PARICALCITOL
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
1MCG
Tentative Approval
PARICALCITOL
paricalcitol
TEVA PHARMS
90829
2010-08-26 Letter
CAPSULE; ORAL
2MCG
Tentative Approval
PARICALCITOL
paricalcitol
TEVA PHARMS
"
CAPSULE; ORAL
4MCG
Tentative Approval
PARICALCITOL
paricalcitol
TEVA PHARMS
"
CAPSULE; ORAL
1MCG
Tentative Approval
PARICALCITOL
paricalcitol
DR REDDYS LABS LTD
91412
CAPSULE; ORAL
2MCG
Tentative Approval
PARICALCITOL
paricalcitol
DR REDDYS LABS LTD
"
CAPSULE; ORAL
4MCG
Tentative Approval
PARICALCITOL
paricalcitol
DR REDDYS LABS LTD
"
INJECTABLE; INJECTION
0.002MG/ML
Prescription
AP
PARICALCITOL
paricalcitol
SANDOZ CANADA INC
91108
2011-07-29 Letter
INJECTABLE; INJECTION
0.005MG/ML
Prescription
AP
PARICALCITOL
paricalcitol
SANDOZ CANADA INC
"
Drug Adverse Effects information for PARICALCITOL
Role code
Indications
Reaction
# Reports
PS
HYPERPARATHYROIDISM SECONDARY
CORONARY ARTERY DISEASE
2
PS
HYPERPARATHYROIDISM SECONDARY
DIZZINESS
2
PS
HYPERPARATHYROIDISM SECONDARY
DYSPNOEA
2
PS
HYPERPARATHYROIDISM SECONDARY
NEOPLASM SKIN
1
PS
HYPERPARATHYROIDISM SECONDARY
POST PROCEDURAL INFECTION
1
PS
HYPERPARATHYROIDISM SECONDARY
VOMITING
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
CORONARY ARTERY DISEASE
12
PS
PRODUCT USED FOR UNKNOWN INDICATION
DIZZINESS
12
PS
PRODUCT USED FOR UNKNOWN INDICATION
DYSPNOEA
12
PS
PRODUCT USED FOR UNKNOWN INDICATION
NEOPLASM SKIN
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
PARATHYROIDECTOMY
7
PS
PRODUCT USED FOR UNKNOWN INDICATION
POST PROCEDURAL INFECTION
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
VOMITING
12
PS
RENAL FAILURE CHRONIC
CORONARY ARTERY DISEASE
1
PS
RENAL FAILURE CHRONIC
DIZZINESS
1
PS
RENAL FAILURE CHRONIC
DYSPNOEA
1
PS
RENAL FAILURE CHRONIC
VOMITING
1
SS
HYPERPARATHYROIDISM SECONDARY
NEOPLASM SKIN
4
SS
HYPERPARATHYROIDISM SECONDARY
POST PROCEDURAL INFECTION
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
NEOPLASM SKIN
8
SS
PRODUCT USED FOR UNKNOWN INDICATION
POST PROCEDURAL INFECTION
8
C
NEPHROGENIC ANAEMIA
ANGINA PECTORIS
6
C
NEPHROGENIC ANAEMIA
ATRIAL FIBRILLATION
4
C
NEPHROGENIC ANAEMIA
ATRIAL FLUTTER
2
C
NEPHROGENIC ANAEMIA
BRONCHOPNEUMONIA
2
C
NEPHROGENIC ANAEMIA
CEREBRAL ATROPHY
2
C
NEPHROGENIC ANAEMIA
CEREBRAL ISCHAEMIA
6
C
NEPHROGENIC ANAEMIA
CEREBROVASCULAR ACCIDENT
2
C
NEPHROGENIC ANAEMIA
CHRONIC MYELOID LEUKAEMIA
6
C
NEPHROGENIC ANAEMIA
CONFUSIONAL STATE
4
C
NEPHROGENIC ANAEMIA
DELIRIUM
4
C
NEPHROGENIC ANAEMIA
FALL
2
C
NEPHROGENIC ANAEMIA
HAEMOGLOBIN DECREASED
4
C
NEPHROGENIC ANAEMIA
HEART RATE INCREASED
2
C
NEPHROGENIC ANAEMIA
HEART VALVE CALCIFICATION
2
C
NEPHROGENIC ANAEMIA
HYPERTENSION
2
C
NEPHROGENIC ANAEMIA
IN-STENT CORONARY ARTERY RESTENOSIS
4
C
NEPHROGENIC ANAEMIA
LETHARGY
4
C
NEPHROGENIC ANAEMIA
MYOCARDIAL INFARCTION
6
C
NEPHROGENIC ANAEMIA
MYOCARDIAL ISCHAEMIA
6
C
NEPHROGENIC ANAEMIA
OSTEOPOROSIS
2
C
NEPHROGENIC ANAEMIA
SPINAL COMPRESSION FRACTURE
6
C
NEPHROGENIC ANAEMIA
SUDDEN DEATH
2
C
NEPHROGENIC ANAEMIA
WRONG DRUG ADMINISTERED
2
C
NUCLEAR MAGNETIC RESONANCE IMAGING
GAIT DISTURBANCE
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
LOCALISED OEDEMA
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
MUSCULOSKELETAL STIFFNESS
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
NEPHROGENIC SYSTEMIC FIBROSIS
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
PAIN
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
PAIN IN EXTREMITY
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
RASH MACULAR
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN FIBROSIS
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN HYPERPIGMENTATION
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN HYPERTROPHY
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN INDURATION
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN PLAQUE
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN TIGHTNESS
3
C
OSTEOPOROSIS
HYPOCALCAEMIA
1
C
OSTEOPOROSIS
PALPITATIONS
1
C
OSTEOPOROSIS
PARAESTHESIA
1
Ads by Google